Pharma Industry News

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. A bunch of people I know (including me) have gotten sick recently. It’s a particularly intense flu season right now. Hope everyone is taking care of themselves.
Read the rest…

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. A bunch of people I know (including me) have gotten sick recently. It’s a particularly intense flu season right now. Hope everyone is taking care of themselves.

Read the rest…

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]